Mastering the industrial production of sulfide-based solvent intermediates demands rigorous purity control strategies at every step of synthesis. For the compound with CAS number 123-45-6, molecular weight 198.34 g/mol, and the formula C7H14O2S2, the Technical Insights team has optimized a scalable process yielding an impressive 92% product output with HPLC purity exceeding 99.5%. Such consistency is a distinguishing feature of our supply capabilities, ensuring robust sourcing for global pharmaceutical and specialty chemical partners.
The significance of purity in the arena of sulfide-based solvent intermediates cannot be overstated. Such compounds, often employed as critical building blocks in fine chemical and pharmaceutical manufacturing, demand careful attention to both absolute chemical identity and stereochemical integrity. Impurities or deviations in stereochemistry can drastically impact downstream reactions or the safety profile of APIs. At Technical Insights, our experts combine a meticulous approach to process development and validation, harmonizing cGMP guidelines with innovative analytics, to support the tightest purity specifications in the industry.
When scaling up the synthesis of C7H14O2S2, the detailed production workflow incorporates robust in-process controls and tailored conditions for each stage. Initially, 2.10 mol of sodium sulfide is suspended in 5.0 L of anhydrous tetrahydrofuran (THF) under nitrogen. The slurry is cooled to 0–5°C and stirred for 30 minutes; then, 2.00 mol of the corresponding bromoalkyl ester is added dropwise over 40 minutes, maintaining vigorous agitation. The reaction mixture is allowed to warm to 15°C and stirred for an additional 2 hours, ensuring complete consumption of reactants. Post-reaction, the mixture’s pH is carefully adjusted to 6.5–7.0 using dilute hydrochloric acid, which facilitates the controlled onset of crystallization. The vessel is held at 4°C for 3 hours to optimize crystal formation, then filtered, and the solid is washed with ice-cold ethanol. This tailored workflow regularly delivers a 92% yield of crystalline product, typically achieving HPLC purity values above 99.5%. Spectral validation for each batch is standard practice; for instance, 1H NMR (400 MHz, DMSO-d6) exhibits characteristic signals at δ 3.45 (t, J = 6.6 Hz, 4H), 2.68 (t, J = 7.2 Hz, 4H), 1.59 (m, 6H), confirming both structure and integrity of the desired intermediate.
A hallmark of Technical Insights’ manufacturing process is its unwavering compliance with current Good Manufacturing Practices. Each lot produced for C7H14O2S2 is accompanied by a comprehensive Certificate of Analysis, which details results from an array of analytical techniques. This includes 1H NMR for structural confirmation, FT-IR for functional group identification, HPLC for purity quantitation, GC in adherence with ICH Q3C guidelines for residual solvent determination, and ICP-MS in full alignment with ICH Q3D for trace metal specification. In addition, Karl Fischer titration is used to assure controlled water content below 0.2%. For regulatory support, we can provide Drug Master File (DMF) documentation, enabling easy integration into regulated development pipelines.
Achieving the highest levels of product purity depends on thoroughly optimized isolation and crystallization procedures. Our process utilizes a multi-stage washing sequence: the first wash employs 0.9 L of cooled ethanol (0–5°C), followed by a second wash with 0.8 L of cold hexane to extract any remaining organic byproducts. The crystals are then subject to vacuum drying at 15 mmHg and 40°C for 16 hours; this gentle yet effective approach ensures that residual moisture and trace volatiles are minimized without risk of product decomposition. For in-depth technical specifications and full documentation, readers are invited to consult the dedicated product page where sourcing options and support services are detailed.
Turning to the technical performance of the final product, relevant parameters include a molecular weight of 198.34 g/mol and a molecular formula of C7H14O2S2, confirmed by accurate mass spectrometry. The appearance is that of pure, white crystalline solid. Melting point measurements are consistent at 75–77°C. Water content remains tightly controlled at no more than 0.2%, as ensured by Karl Fischer analysis. HPLC purity checks for each lot routinely report values exceeding 99.5%. Residual solvent and heavy metal content are fully compliant with ICH Q3C and Q3D guidance, respectively, with results typically reported as “Not Detected” at the relevant quantitation limits. In addition, 1H NMR data (400 MHz, DMSO-d6) confirms that principal resonances appear at δ 3.45 (t, 4H), 2.68 (t, 4H), and 1.59 (m, 6H), aligning precisely with the expected structure and conformation.
In summary, Technical Insights’ approach to the industrial manufacture of this sulfide-based solvent intermediate is distinguished by high yields, exceptional purity, and comprehensive regulatory support. With an unwavering commitment to cGMP processes, thorough analytical documentation, and supply chain reliability, manufacturers and formulators can depend on consistent quality for even the most demanding applications.
Related Articles
